文献速递脊柱脊髓外科神经肿瘤

不可切除的胸椎Rosai-Dorfman病:一例病例报告与文献综述

Nonresectable Thoracic Rosai-Dorfman Disease: A Case Report and Review of the Literature.
PubMed 文献 · World Neurosurg · 2019-09-13

本文报告一例32岁男性乙型肝炎病毒感染者,因外伤后腰背痛伴下肢无力先后接受T11-12椎板减压术与硬膜切除术,3年后确诊复发RDD,加用沙利度胺治疗,9年随访无复发及神经功能缺损,并结合文献讨论脊柱RDD的诊疗策略。

要点

  • 脊柱RDD罕见且易误诊,术后需长期随访以监测复发。
  • 手术仍是首选治疗,但复发或不可切除病例可辅以沙利度胺等药物治疗。
  • 本例沙利度胺治疗不可切除复发性RDD,9年随访无复发及神经功能缺损。

核心结论

  • RDD罕见且可自发缓解,但存在复发可能,因此需要广泛随访。
  • 手术仍是首选治疗方式,但遇到复发或不可切除的RDD时,糖皮质激素、沙利度胺和放疗等辅助治疗可能有帮助。
  • 本文分享了使用沙利度胺治疗不可切除RDD的经验。

研究设计与样本

  • 病例报告并附文献综述:一例32岁男性乙型肝炎病毒感染者,外伤后出现腰背痛伴下肢无力。

主要发现

  • 患者先行T11-12椎板切除术减压脊髓,最终病理示慢性炎症,术后下肢症状改善。
  • 3年后症状复发并确诊为RDD,遂行硬膜切除术并用人工硬膜修复,同时开始沙利度胺治疗。
  • 沙利度胺治疗9年后,患者未出现复发或任何形式的神经功能缺损。

临床怎么用

  • 脊柱RDD诊断需警惕误诊,术后应长期随访以监测复发。
  • 对复发或不可切除的脊柱RDD,可考虑在手术基础上加用沙利度胺等辅助治疗。

局限性

  • 本文为单例病例报告,经验外推需谨慎;原文未系统报告辅助治疗的剂量与疗程等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Rosai-Dorfman disease (RDD) is a rare disease that can be triggered by either viral or bacterial infection. Several parts of the body can be involved, from the central nervous system to the pelvic regions had been reported. At present, there is a serious lack of guidelines as to how to treat cases of RDD involving the spine. Current trends show that surgery remains the first method of choice to cure this disease, but in refractory or recurrent RDD, repeat surgery cannot guarantee total resection. Under such circumstances, adjuvant therapy can be very useful. Here, we share our experience of treating recurrent spinal RDD. CASE DESCRIPTION: Our patient was a 32-year-old male patient with hepatitis B virus infection. He suffered from lower back pain with lower limb weakness after being hit by a metal pipe. Laminectomy of T11-12 was performed to decompress the spinal cord. The final pathological results demonstrated chronic inflammation. After surgery, the lower limbs improved and the patient recovered quite well. However, he returned 3 years later with the same complaints and was diagnosed with RDD. Durectomy was performed and repaired with an artificial dura. Thalidomide therapy was initiated. Currently, 9 years later, the patient has not experienced recurrence or any form of neurological deficit. CONCLUSIONS: RDD is a rare disease and can be misdiagnosed easily. Although it may resolve spontaneously, recurrence is possible. Hence, extensive follow-up is necessary. Surgery remained the first choice of surgery, however, when encountered recurrent or nonresectable RDD, adjuvant therapy such as corticosteroids, thalidomide, and radiotherapy could help. In this article, we shared our experience using thalidomide in treating nonresectable RDD.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lin CK, Tsai YD. Nonresectable Thoracic Rosai-Dorfman Disease: A Case Report and Review of the Literature. World Neurosurg. 2019. PMID: 31525482. doi:10.1016/j.wneu.2019.09.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。